Literature DB >> 11788835

Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.

Jiayuan Tong1, Frances Hannan, Yinghua Zhu, Andre Bernards, Yi Zhong.   

Abstract

Neurofibromatosis type 1 (NF1) is a dominant genetic disorder characterized by multiple benign and malignant nervous system tumors, and by learning defects in 45% of children with NF1 mutations. Studies of neurofibromin, the protein encoded by NF1, have focused on its functions in tumorigenesis and regulation of Ras activity; however, Drosophila NF1 regulates both Ras and cyclic AMP (cAMP) pathways. Expression of a human NF1 transgene rescued cAMP-related phenotypes in NF1 mutant flies (small body size and G protein-stimulated adenylyl cyclase (AC) activity defects), and neuropeptide- and G protein-stimulated AC activity were lower in Nf1-/- as compared to Nf1+/- mouse brains, demonstrating that neurofibromin regulates AC activity in both mammals and flies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788835     DOI: 10.1038/nn792

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  80 in total

1.  CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Authors:  Tao Sun; Scott M Gianino; Erin Jackson; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  J Neuroimmunol       Date:  2010-07-27       Impact factor: 3.478

Review 2.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 3.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

4.  Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.

Authors:  James A Walker; Anna V Tchoudakova; Peter T McKenney; Suzanne Brill; Dongyun Wu; Glenn S Cowley; Iswar K Hariharan; André Bernards
Journal:  Genes Dev       Date:  2006-11-17       Impact factor: 11.361

5.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.

Authors:  Bing Gong; Ottavio V Vitolo; Fabrizio Trinchese; Shumin Liu; Michael Shelanski; Ottavio Arancio
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  State-dependent Ras signaling and AMPA receptor trafficking.

Authors:  Yi Qin; Yinghua Zhu; Joel P Baumgart; Ruth L Stornetta; Kenneth Seidenman; Volker Mack; Linda van Aelst; J Julius Zhu
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

7.  HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Authors:  A Omrani; T van der Vaart; E Mientjes; G M van Woerden; M R Hojjati; K W Li; D H Gutmann; C N Levelt; A B Smit; A J Silva; S A Kushner; Y Elgersma
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

Review 8.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

9.  Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction.

Authors:  Serge H Ahmed; Robert Lutjens; Lena D van der Stap; Dusan Lekic; Vincenzo Romano-Spica; Marisela Morales; George F Koob; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

10.  Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.

Authors:  Kelly A Diggs-Andrews; Kazuhiro Tokuda; Yukitoshi Izumi; Charles F Zorumski; David F Wozniak; David H Gutmann
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.